Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Oral Rotavirus Vaccine Market Growth 2022-2028

  • LP 4837980
  • 93 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Oral Rotavirus Vaccine will have significant change from previous year. According to our (LP Information) latest study, the global Oral Rotavirus Vaccine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Oral Rotavirus Vaccine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Oral Rotavirus Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Oral Rotavirus Vaccine market, reaching US$ million by the year 2028. As for the Europe Oral Rotavirus Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Oral Rotavirus Vaccine players cover GSK, Sanofi-Pasteur, Merck, and Biological E. Limited, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Oral Rotavirus Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Rotarix

RotaTeq

Rotavac

Rotavin-M1

Lanzhou lamb

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital

Vaccination Station

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

GSK

Sanofi-Pasteur

Merck

Biological E. Limited

China National Biotec Group

Sinovac Biotech

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Oral Rotavirus Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Oral Rotavirus Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Oral Rotavirus Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Oral Rotavirus Vaccine Segment by Type

2.2.1 Rotarix

2.2.2 RotaTeq

2.2.3 Rotavac

2.2.4 Rotavin-M1

2.2.5 Lanzhou lamb

2.3 Oral Rotavirus Vaccine Sales by Type

2.3.1 Global Oral Rotavirus Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Oral Rotavirus Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Oral Rotavirus Vaccine Sale Price by Type (2017-2022)

2.4 Oral Rotavirus Vaccine Segment by Application

2.4.1 Hospital

2.4.2 Vaccination Station

2.4.3 Other

2.5 Oral Rotavirus Vaccine Sales by Application

2.5.1 Global Oral Rotavirus Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Oral Rotavirus Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Oral Rotavirus Vaccine Sale Price by Application (2017-2022)

3 Global Oral Rotavirus Vaccine by Company

3.1 Global Oral Rotavirus Vaccine Breakdown Data by Company

3.1.1 Global Oral Rotavirus Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Oral Rotavirus Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Oral Rotavirus Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Oral Rotavirus Vaccine Revenue by Company (2020-2022)

3.2.2 Global Oral Rotavirus Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Oral Rotavirus Vaccine Sale Price by Company

3.4 Key Manufacturers Oral Rotavirus Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Oral Rotavirus Vaccine Product Location Distribution

3.4.2 Players Oral Rotavirus Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Oral Rotavirus Vaccine by Geographic Region

4.1 World Historic Oral Rotavirus Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Oral Rotavirus Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Oral Rotavirus Vaccine Annual Revenue by Geographic Region

4.2 World Historic Oral Rotavirus Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Oral Rotavirus Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Oral Rotavirus Vaccine Annual Revenue by Country/Region

4.3 Americas Oral Rotavirus Vaccine Sales Growth

4.4 APAC Oral Rotavirus Vaccine Sales Growth

4.5 Europe Oral Rotavirus Vaccine Sales Growth

4.6 Middle East & Africa Oral Rotavirus Vaccine Sales Growth

5 Americas

5.1 Americas Oral Rotavirus Vaccine Sales by Country

5.1.1 Americas Oral Rotavirus Vaccine Sales by Country (2017-2022)

5.1.2 Americas Oral Rotavirus Vaccine Revenue by Country (2017-2022)

5.2 Americas Oral Rotavirus Vaccine Sales by Type

5.3 Americas Oral Rotavirus Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Oral Rotavirus Vaccine Sales by Region

6.1.1 APAC Oral Rotavirus Vaccine Sales by Region (2017-2022)

6.1.2 APAC Oral Rotavirus Vaccine Revenue by Region (2017-2022)

6.2 APAC Oral Rotavirus Vaccine Sales by Type

6.3 APAC Oral Rotavirus Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Oral Rotavirus Vaccine by Country

7.1.1 Europe Oral Rotavirus Vaccine Sales by Country (2017-2022)

7.1.2 Europe Oral Rotavirus Vaccine Revenue by Country (2017-2022)

7.2 Europe Oral Rotavirus Vaccine Sales by Type

7.3 Europe Oral Rotavirus Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Oral Rotavirus Vaccine by Country

8.1.1 Middle East & Africa Oral Rotavirus Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Oral Rotavirus Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Oral Rotavirus Vaccine Sales by Type

8.3 Middle East & Africa Oral Rotavirus Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Oral Rotavirus Vaccine

10.3 Manufacturing Process Analysis of Oral Rotavirus Vaccine

10.4 Industry Chain Structure of Oral Rotavirus Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Oral Rotavirus Vaccine Distributors

11.3 Oral Rotavirus Vaccine Customer

12 World Forecast Review for Oral Rotavirus Vaccine by Geographic Region

12.1 Global Oral Rotavirus Vaccine Market Size Forecast by Region

12.1.1 Global Oral Rotavirus Vaccine Forecast by Region (2023-2028)

12.1.2 Global Oral Rotavirus Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Oral Rotavirus Vaccine Forecast by Type

12.7 Global Oral Rotavirus Vaccine Forecast by Application

13 Key Players Analysis

13.1 GSK

13.1.1 GSK Company Information

13.1.2 GSK Oral Rotavirus Vaccine Product Offered

13.1.3 GSK Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 GSK Main Business Overview

13.1.5 GSK Latest Developments

13.2 Sanofi-Pasteur

13.2.1 Sanofi-Pasteur Company Information

13.2.2 Sanofi-Pasteur Oral Rotavirus Vaccine Product Offered

13.2.3 Sanofi-Pasteur Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Sanofi-Pasteur Main Business Overview

13.2.5 Sanofi-Pasteur Latest Developments

13.3 Merck

13.3.1 Merck Company Information

13.3.2 Merck Oral Rotavirus Vaccine Product Offered

13.3.3 Merck Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Merck Main Business Overview

13.3.5 Merck Latest Developments

13.4 Biological E. Limited

13.4.1 Biological E. Limited Company Information

13.4.2 Biological E. Limited Oral Rotavirus Vaccine Product Offered

13.4.3 Biological E. Limited Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Biological E. Limited Main Business Overview

13.4.5 Biological E. Limited Latest Developments

13.5 China National Biotec Group

13.5.1 China National Biotec Group Company Information

13.5.2 China National Biotec Group Oral Rotavirus Vaccine Product Offered

13.5.3 China National Biotec Group Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 China National Biotec Group Main Business Overview

13.5.5 China National Biotec Group Latest Developments

13.6 Sinovac Biotech

13.6.1 Sinovac Biotech Company Information

13.6.2 Sinovac Biotech Oral Rotavirus Vaccine Product Offered

13.6.3 Sinovac Biotech Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Sinovac Biotech Main Business Overview

13.6.5 Sinovac Biotech Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Oral Rotavirus Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Oral Rotavirus Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Rotarix

Table 4. Major Players of RotaTeq

Table 5. Major Players of Rotavac

Table 6. Major Players of Rotavin-M1

Table 7. Major Players of Lanzhou lamb

Table 8. Global Oral Rotavirus Vaccine Sales by Type (2017-2022) & (K Pcs)

Table 9. Global Oral Rotavirus Vaccine Sales Market Share by Type (2017-2022)

Table 10. Global Oral Rotavirus Vaccine Revenue by Type (2017-2022) & ($ million)

Table 11. Global Oral Rotavirus Vaccine Revenue Market Share by Type (2017-2022)

Table 12. Global Oral Rotavirus Vaccine Sale Price by Type (2017-2022) & (USD/Pcs)

Table 13. Global Oral Rotavirus Vaccine Sales by Application (2017-2022) & (K Pcs)

Table 14. Global Oral Rotavirus Vaccine Sales Market Share by Application (2017-2022)

Table 15. Global Oral Rotavirus Vaccine Revenue by Application (2017-2022)

Table 16. Global Oral Rotavirus Vaccine Revenue Market Share by Application (2017-2022)

Table 17. Global Oral Rotavirus Vaccine Sale Price by Application (2017-2022) & (USD/Pcs)

Table 18. Global Oral Rotavirus Vaccine Sales by Company (2020-2022) & (K Pcs)

Table 19. Global Oral Rotavirus Vaccine Sales Market Share by Company (2020-2022)

Table 20. Global Oral Rotavirus Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Oral Rotavirus Vaccine Revenue Market Share by Company (2020-2022)

Table 22. Global Oral Rotavirus Vaccine Sale Price by Company (2020-2022) & (USD/Pcs)

Table 23. Key Manufacturers Oral Rotavirus Vaccine Producing Area Distribution and Sales Area

Table 24. Players Oral Rotavirus Vaccine Products Offered

Table 25. Oral Rotavirus Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Oral Rotavirus Vaccine Sales by Geographic Region (2017-2022) & (K Pcs)

Table 29. Global Oral Rotavirus Vaccine Sales Market Share Geographic Region (2017-2022)

Table 30. Global Oral Rotavirus Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Oral Rotavirus Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Oral Rotavirus Vaccine Sales by Country/Region (2017-2022) & (K Pcs)

Table 33. Global Oral Rotavirus Vaccine Sales Market Share by Country/Region (2017-2022)

Table 34. Global Oral Rotavirus Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Oral Rotavirus Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Oral Rotavirus Vaccine Sales by Country (2017-2022) & (K Pcs)

Table 37. Americas Oral Rotavirus Vaccine Sales Market Share by Country (2017-2022)

Table 38. Americas Oral Rotavirus Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Oral Rotavirus Vaccine Revenue Market Share by Country (2017-2022)

Table 40. Americas Oral Rotavirus Vaccine Sales by Type (2017-2022) & (K Pcs)

Table 41. Americas Oral Rotavirus Vaccine Sales Market Share by Type (2017-2022)

Table 42. Americas Oral Rotavirus Vaccine Sales by Application (2017-2022) & (K Pcs)

Table 43. Americas Oral Rotavirus Vaccine Sales Market Share by Application (2017-2022)

Table 44. APAC Oral Rotavirus Vaccine Sales by Region (2017-2022) & (K Pcs)

Table 45. APAC Oral Rotavirus Vaccine Sales Market Share by Region (2017-2022)

Table 46. APAC Oral Rotavirus Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Oral Rotavirus Vaccine Revenue Market Share by Region (2017-2022)

Table 48. APAC Oral Rotavirus Vaccine Sales by Type (2017-2022) & (K Pcs)

Table 49. APAC Oral Rotavirus Vaccine Sales Market Share by Type (2017-2022)

Table 50. APAC Oral Rotavirus Vaccine Sales by Application (2017-2022) & (K Pcs)

Table 51. APAC Oral Rotavirus Vaccine Sales Market Share by Application (2017-2022)

Table 52. Europe Oral Rotavirus Vaccine Sales by Country (2017-2022) & (K Pcs)

Table 53. Europe Oral Rotavirus Vaccine Sales Market Share by Country (2017-2022)

Table 54. Europe Oral Rotavirus Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Oral Rotavirus Vaccine Revenue Market Share by Country (2017-2022)

Table 56. Europe Oral Rotavirus Vaccine Sales by Type (2017-2022) & (K Pcs)

Table 57. Europe Oral Rotavirus Vaccine Sales Market Share by Type (2017-2022)

Table 58. Europe Oral Rotavirus Vaccine Sales by Application (2017-2022) & (K Pcs)

Table 59. Europe Oral Rotavirus Vaccine Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Oral Rotavirus Vaccine Sales by Country (2017-2022) & (K Pcs)

Table 61. Middle East & Africa Oral Rotavirus Vaccine Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Oral Rotavirus Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Oral Rotavirus Vaccine Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Oral Rotavirus Vaccine Sales by Type (2017-2022) & (K Pcs)

Table 65. Middle East & Africa Oral Rotavirus Vaccine Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Oral Rotavirus Vaccine Sales by Application (2017-2022) & (K Pcs)

Table 67. Middle East & Africa Oral Rotavirus Vaccine Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Oral Rotavirus Vaccine

Table 69. Key Market Challenges & Risks of Oral Rotavirus Vaccine

Table 70. Key Industry Trends of Oral Rotavirus Vaccine

Table 71. Oral Rotavirus Vaccine Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Oral Rotavirus Vaccine Distributors List

Table 74. Oral Rotavirus Vaccine Customer List

Table 75. Global Oral Rotavirus Vaccine Sales Forecast by Region (2023-2028) & (K Pcs)

Table 76. Global Oral Rotavirus Vaccine Sales Market Forecast by Region

Table 77. Global Oral Rotavirus Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Oral Rotavirus Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Oral Rotavirus Vaccine Sales Forecast by Country (2023-2028) & (K Pcs)

Table 80. Americas Oral Rotavirus Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Oral Rotavirus Vaccine Sales Forecast by Region (2023-2028) & (K Pcs)

Table 82. APAC Oral Rotavirus Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Oral Rotavirus Vaccine Sales Forecast by Country (2023-2028) & (K Pcs)

Table 84. Europe Oral Rotavirus Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Oral Rotavirus Vaccine Sales Forecast by Country (2023-2028) & (K Pcs)

Table 86. Middle East & Africa Oral Rotavirus Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Oral Rotavirus Vaccine Sales Forecast by Type (2023-2028) & (K Pcs)

Table 88. Global Oral Rotavirus Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Oral Rotavirus Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Oral Rotavirus Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Oral Rotavirus Vaccine Sales Forecast by Application (2023-2028) & (K Pcs)

Table 92. Global Oral Rotavirus Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Oral Rotavirus Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Oral Rotavirus Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 95. GSK Basic Information, Oral Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 96. GSK Oral Rotavirus Vaccine Product Offered

Table 97. GSK Oral Rotavirus Vaccine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 98. GSK Main Business

Table 99. GSK Latest Developments

Table 100. Sanofi-Pasteur Basic Information, Oral Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 101. Sanofi-Pasteur Oral Rotavirus Vaccine Product Offered

Table 102. Sanofi-Pasteur Oral Rotavirus Vaccine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 103. Sanofi-Pasteur Main Business

Table 104. Sanofi-Pasteur Latest Developments

Table 105. Merck Basic Information, Oral Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 106. Merck Oral Rotavirus Vaccine Product Offered

Table 107. Merck Oral Rotavirus Vaccine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 108. Merck Main Business

Table 109. Merck Latest Developments

Table 110. Biological E. Limited Basic Information, Oral Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 111. Biological E. Limited Oral Rotavirus Vaccine Product Offered

Table 112. Biological E. Limited Oral Rotavirus Vaccine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 113. Biological E. Limited Main Business

Table 114. Biological E. Limited Latest Developments

Table 115. China National Biotec Group Basic Information, Oral Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 116. China National Biotec Group Oral Rotavirus Vaccine Product Offered

Table 117. China National Biotec Group Oral Rotavirus Vaccine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 118. China National Biotec Group Main Business

Table 119. China National Biotec Group Latest Developments

Table 120. Sinovac Biotech Basic Information, Oral Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 121. Sinovac Biotech Oral Rotavirus Vaccine Product Offered

Table 122. Sinovac Biotech Oral Rotavirus Vaccine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 123. Sinovac Biotech Main Business

Table 124. Sinovac Biotech Latest Developments

List of Figures

Figure 1. Picture of Oral Rotavirus Vaccine

Figure 2. Oral Rotavirus Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Oral Rotavirus Vaccine Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Oral Rotavirus Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Oral Rotavirus Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Rotarix

Figure 10. Product Picture of RotaTeq

Figure 11. Product Picture of Rotavac

Figure 12. Product Picture of Rotavin-M1

Figure 13. Product Picture of Lanzhou lamb

Figure 14. Global Oral Rotavirus Vaccine Sales Market Share by Type in 2021

Figure 15. Global Oral Rotavirus Vaccine Revenue Market Share by Type (2017-2022)

Figure 16. Oral Rotavirus Vaccine Consumed in Hospital

Figure 17. Global Oral Rotavirus Vaccine Market: Hospital (2017-2022) & (K Pcs)

Figure 18. Oral Rotavirus Vaccine Consumed in Vaccination Station

Figure 19. Global Oral Rotavirus Vaccine Market: Vaccination Station (2017-2022) & (K Pcs)

Figure 20. Oral Rotavirus Vaccine Consumed in Other

Figure 21. Global Oral Rotavirus Vaccine Market: Other (2017-2022) & (K Pcs)

Figure 22. Global Oral Rotavirus Vaccine Sales Market Share by Application (2017-2022)

Figure 23. Global Oral Rotavirus Vaccine Revenue Market Share by Application in 2021

Figure 24. Oral Rotavirus Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Oral Rotavirus Vaccine Revenue Market Share by Company in 2021

Figure 26. Global Oral Rotavirus Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Oral Rotavirus Vaccine Revenue Market Share by Geographic Region in 2021

Figure 28. Global Oral Rotavirus Vaccine Sales Market Share by Region (2017-2022)

Figure 29. Global Oral Rotavirus Vaccine Revenue Market Share by Country/Region in 2021

Figure 30. Americas Oral Rotavirus Vaccine Sales 2017-2022 (K Pcs)

Figure 31. Americas Oral Rotavirus Vaccine Revenue 2017-2022 ($ Millions)

Figure 32. APAC Oral Rotavirus Vaccine Sales 2017-2022 (K Pcs)

Figure 33. APAC Oral Rotavirus Vaccine Revenue 2017-2022 ($ Millions)

Figure 34. Europe Oral Rotavirus Vaccine Sales 2017-2022 (K Pcs)

Figure 35. Europe Oral Rotavirus Vaccine Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Oral Rotavirus Vaccine Sales 2017-2022 (K Pcs)

Figure 37. Middle East & Africa Oral Rotavirus Vaccine Revenue 2017-2022 ($ Millions)

Figure 38. Americas Oral Rotavirus Vaccine Sales Market Share by Country in 2021

Figure 39. Americas Oral Rotavirus Vaccine Revenue Market Share by Country in 2021

Figure 40. United States Oral Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Oral Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Oral Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Oral Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Oral Rotavirus Vaccine Sales Market Share by Region in 2021

Figure 45. APAC Oral Rotavirus Vaccine Revenue Market Share by Regions in 2021

Figure 46. China Oral Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Oral Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Oral Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Oral Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Oral Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Oral Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Oral Rotavirus Vaccine Sales Market Share by Country in 2021

Figure 53. Europe Oral Rotavirus Vaccine Revenue Market Share by Country in 2021

Figure 54. Germany Oral Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Oral Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Oral Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Oral Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Oral Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Oral Rotavirus Vaccine Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Oral Rotavirus Vaccine Revenue Market Share by Country in 2021

Figure 61. Egypt Oral Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Oral Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Oral Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Oral Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Oral Rotavirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Oral Rotavirus Vaccine in 2021

Figure 67. Manufacturing Process Analysis of Oral Rotavirus Vaccine

Figure 68. Industry Chain Structure of Oral Rotavirus Vaccine

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390